Zontivity Dosage
Generic name: VORAPAXAR SULFATE 2.08mg
Dosage form: tablet, film coated
Drug class: Protease-activated receptor-1 antagonists
Medically reviewed by Drugs.com. Last updated on Oct 8, 2024.
General Dosing Information
Take one tablet of ZONTIVITY 2.08 mg orally once daily, with or without food.
Coadministration with Other Antiplatelet Drugs
There is no experience with use of ZONTIVITY alone as the only administered antiplatelet agent. ZONTIVITY has been studied only as an addition to aspirin and/or clopidogrel. Use ZONTIVITY with aspirin and/or clopidogrel according to their indications or standard of care . There is limited clinical experience with other antiplatelet drugs.
More about Zontivity (vorapaxar)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- During pregnancy
- FDA approval history
- Drug class: protease-activated receptor-1 antagonists
- En español
Patient resources
Professional resources
Related treatment guides
See also:
Xarelto
Xarelto (rivaroxaban) is a factor Xa inhibitor used to reduce the risk of blood clots and stroke in ...
Plavix
Plavix (clopidogrel) is used to prevent blood clots after a recent heart attack or stroke. Includes ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Brilinta
Brilinta (ticagrelor) is used to lower your risk of having a stroke or serious heart problems after ...
Eliquis
Eliquis (apixaban) is used to reduce the risk of stroke and systemic embolism in patients with ...
Coumadin
Coumadin is used to prevent heart attacks, strokes, and blood clots in veins and arteries. Learn ...
Pradaxa
Pradaxa (dabigatran) is used to prevent stroke and blood clots in patients with atrial ...
Doxazosin
Doxazosin is used to treat hypertension (high blood pressure) and benign prostatic hyperplasia ...
Heparin
Heparin injection is used to treat and prevent blood clots in the veins, arteries, or lungs. Learn ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
